Irene Tsung

6PUBLICATIONS
17CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Oct 09, 2025
Reply to "From treatment escalation to ultra de-intensification: When androgen-deprivation therapy alone remains a rational choice in metastatic hormone-sensitive prostate cancer".

Irene Tsung, Zachery R Reichert

|Sep 16, 2025
Multicenter Phase II Study of Olaparib and the ATR Inhibitor Ceralasertib in Metastatic Castration-Resistant Prostate Cancer (TRAP).

Irene Tsung, David C Smith, Elisabeth I Heath

|Aug 07, 2025
Controversies in metastatic hormone-sensitive prostate cancer.

Irene Tsung, Sarah E Yentz, Zachery R Reichert

|Nov 01, 2022
A Phase 2 Trial of Nab-paclitaxel in Combination With Anti-PD1 Therapy in Advanced Urothelial Cancer.

Irene Tsung, Edward Green, Phillip Palmbos

|Mar 02, 2022
Infrequent liver injury from cemiplimab in patients with advanced cutaneous squamous cell carcinoma.

Linnea Swanson, Ihab Kassab, Irene Tsung

|Sep 24, 2020
A Pilot Study of Checkpoint Inhibitors in Solid Organ Transplant Recipients with Metastatic Cutaneous Squamous Cell Carcinoma.

Irene Tsung, Francis P Worden, Robert J Fontana

Pageof 1

Frequent Collaborators

3 joint publications

Zachery R Reichert

1 joint publications

Linnea Swanson

1 joint publications

Ihab Kassab

1 joint publications

Robert J Fontana